Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (621-630 of 831) with videos related to

Pageof 84
Sort By:
Radiation Oncology (London, England)|October 28, 2024
Influence of brain metastases on the classification, treatment, and outcome of patients with extracranial oligometastasis: a single-center cross-sectional analysisSebastian M Christ, Gabriel W Thiel, Philip Heesen, et al.
Neuro-Oncology Advances|July 10, 2026
Neurosurgeons' perspective on surgical treatment of glioblastoma: Practices, beliefs and willingness to randomize in surgical trialsJohnny Duerinck, Louise Lescrauwaet, Philipp Karschnia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomideWolfgang Wick, Christian Hartmann, Corinna Engel, et al.
Neuro-Oncology|April 10, 2017
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)Riccardo Soffietti, Ufuk Abacioglu, Brigitta Baumert, et al.
Cancer Medicine|September 29, 2020
Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genesTobias Kessler, Anne Berberich, Ahmed Sadik, et al.
Neuro-Oncology|August 8, 2018
Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progressionRaymond Y Huang, Prashin Unadkat, Wenya Linda Bi, et al.
JAMA Oncology|May 22, 2020
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical TrialDavid A Reardon, Alba A Brandes, Antonio Omuro, et al.
Neuro-Oncology|February 27, 2023
Diagnosis and management of complications from the treatment of primary central nervous system tumors in adultsMichael Weller, Emilie Le Rhun, Martin Van den Bent, et al.
Neuro-Oncology|January 23, 2019
Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applicationsAdrienne Boire, Dieta Brandsma, Priscilla K Brastianos, et al.
The Lancet. Oncology|October 26, 2010
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trialEckhard Thiel, Agnieszka Korfel, Peter Martus, et al.
Pageof 84

Showing results (621-630 of 831) with videos related to

Sort By:
Pageof 84
Radiation Oncology (London, England)|October 28, 2024
Influence of brain metastases on the classification, treatment, and outcome of patients with extracranial oligometastasis: a single-center cross-sectional analysisSebastian M Christ, Gabriel W Thiel, Philip Heesen, et al.
Neuro-Oncology Advances|July 10, 2026
Neurosurgeons' perspective on surgical treatment of glioblastoma: Practices, beliefs and willingness to randomize in surgical trialsJohnny Duerinck, Louise Lescrauwaet, Philipp Karschnia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomideWolfgang Wick, Christian Hartmann, Corinna Engel, et al.
Neuro-Oncology|April 10, 2017
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)Riccardo Soffietti, Ufuk Abacioglu, Brigitta Baumert, et al.
Cancer Medicine|September 29, 2020
Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genesTobias Kessler, Anne Berberich, Ahmed Sadik, et al.
Neuro-Oncology|August 8, 2018
Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progressionRaymond Y Huang, Prashin Unadkat, Wenya Linda Bi, et al.
JAMA Oncology|May 22, 2020
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical TrialDavid A Reardon, Alba A Brandes, Antonio Omuro, et al.
Neuro-Oncology|February 27, 2023
Diagnosis and management of complications from the treatment of primary central nervous system tumors in adultsMichael Weller, Emilie Le Rhun, Martin Van den Bent, et al.
Neuro-Oncology|January 23, 2019
Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applicationsAdrienne Boire, Dieta Brandsma, Priscilla K Brastianos, et al.
The Lancet. Oncology|October 26, 2010
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trialEckhard Thiel, Agnieszka Korfel, Peter Martus, et al.
Pageof 84